Present state of the Mini-Invasive Surgery (MIS) in esophageal and gastric cancer.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
J S AzagraI Siciliano

Abstract

The purpose of this review is to stress the role of the Mini-Invasive Surgery (MIS) in the treatment of the esophagogastric malignant illnesses, supporting ourselves on the most relevant publications of the literature as well as on our own experience in this subject. In short, although no randomised prospective study has proven the MIS advantages in relation to the traditional surgery in the esophagectomy due to cancer, some authors preferently indicate this approach to selected and informed enough patients, who present the following: - High grade dysplasia, preferently choosing from laparoscopic transhiatal esophagectomy (LTE). - Carcinoma in situ, preferently choosing the LTE vs thoracoscopy. - Esophageal tumour locally advanced, in resectable patients with contraindication for a thoracotomy or, in initially non-resectable patients with tumoral reduction after neo-adjuvant chemo-radiotherapy. The arguments given by the authors are the postoperative spectacular improvement in relation to the comfort and quality of life and, the absence of oncological negative effects in the long-term followup. Concerning gastric cancer, the MIS, as exeresis surgical tool in the so-called <<advanced>> gastric forms, is such a definite and oncol...Continue Reading

References

Mar 1, 1995·The British Journal of Surgery·R G MolloyJ R Anderson
Feb 1, 1995·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M HünerbeinP M Schlag
Oct 1, 1994·American Journal of Surgery·N SadanagaK Sugimachi
Sep 1, 1993·The Annals of Thoracic Surgery·J M CollardP J Kestens
Mar 1, 1993·The British Journal of Surgery·J S AzagraM Mathys
May 1, 1993·Journal of Computer Assisted Tomography·H van OverhagenH E Schütte
Apr 1, 1996·The Annals of Thoracic Surgery·P E Van SchilJ M van den Bosch
Apr 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·M J KrasnaJ McLaughlin
Jan 1, 1997·Journal of Computer Assisted Tomography·T FukuyaK Masuda
Dec 3, 1998·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·L E HarrisonM F Brennan
Jan 8, 1999·World Journal of Surgery·M OhgamiM Kitajima
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K MaruyamaO Dahl
Jan 29, 1999·Annals of Surgery·Y AdachiK Akazawa
Mar 25, 1999·The New England Journal of Medicine·J J BonenkampUNKNOWN Dutch Gastric Cancer Group
Mar 27, 1999·Surgical Endoscopy·J S AzagraJ Ibañez-Aguirre
Aug 5, 1999·Endoscopy·H FeussnerJ R Siewert
Mar 9, 2000·World Journal of Surgery·G B DogliettoF Crucitti
Mar 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S MsikaJ Faivre
May 3, 2000·Annals of Surgical Oncology·L F Oñate-OcañaJ M Ruiz-Molina
Jul 10, 2001·Surgical Endoscopy·Y AdachiS Kitano
Jan 30, 2002·Journal of Surgical Oncology·Jin-Pok Kim
Feb 2, 2002·American Journal of Clinical Oncology·Dan GreenRicardo Sosa-Sanchez
Jun 25, 2002·Surgical Laparoscopy, Endoscopy & Percutaneous Techniques·Seigo KitanoYosuke Adachi
Jul 9, 2002·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Ettore MarubiniUNKNOWN Gastrointestinal Tumor Study Group
Aug 23, 2002·Annals of Surgery·Farzaneh BankiTom R DeMeester
Aug 24, 2002·Surgical Laparoscopy, Endoscopy & Percutaneous Techniques·Mark J KrasnaCharles White
Oct 8, 2003·Annals of Surgery·James D LuketichHiran C Fernando
Nov 25, 2003·BMJ : British Medical Journal·Peter McCullochUNKNOWN British Oesophago-Gastric Cancer Group
Dec 24, 2003·Surgical Endoscopy·S Kitano, N Shiraishi
Mar 17, 2004·Annals of Surgical Oncology·Maria BurianJ Rüdiger Siewert
Jun 24, 2004·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·Blair A JobeJohn G Hunter
Jun 26, 2004·Surgical Endoscopy·W T Van den BroekM A Cuesta
Nov 25, 2004·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·M YchouUNKNOWN Fédération Française de Cancérologie
Dec 28, 2004·American Journal of Surgery·Cristiano G HuscherFrancesca Piro

❮ Previous
Next ❯

Citations

May 2, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F J LacuevaR Calpena

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Josep RoigAntoni Codina
The Surgical Clinics of North America
R B Lee, J I Miller
© 2022 Meta ULC. All rights reserved